课题基金 / 基金详情

ISOBIOTICS: Isotopic Labeling of Biotherapeutics

ISOBIOTICS: Isotopic Labeling of Biotherapeutics
ISOBIOTICS:生物治疗药物的同位素标记
批准号:
EP/X039501/1
负责人:
Benjamin Davis
金额:
$33.8万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
已结题
起止时间:
2023 至 --

项目摘要

项目成果

Benjamin Davis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Biological drugs such as peptides, proteins, oligonucleotides and analogs provide the patients with more efficacious and less toxic treatments and have lower attrition rates than chemical drugs since 1 on 9 new biological entities entering clinical trials reaches the market (1 on 16 for chemical drugs). Consequently, 15 on 24 top blockbuster drugs were biotherapeutics in 2020 (world-market share of about 40% of $175 billion of revenue per year). In order to reduce the immunogenicity of biodrugs, to overcome their fragility and to increase their capacity to reach quickly and massively their target, reduced-size biologics are extensively developed. However, radiolabeling of large molecules by grafting bifunctional chelating agents which do not alter significantly their biological activity is thus no longer possible with smaller biodrugs. It is therefore of paramount importance to devise new radiolabeling approaches carried out on tiny quantities in aqueous media and very soft conditions. It is also crucial to train a new generation of radiochemists in order to implement these methods and to meet the needs of the European industry. ISOBIOTICS ambitions: 1) to develop new chemically-benign strategies for the last-stage radiolabeling of large peptides, small/medium-size proteins, oligonucleotides and analogs with deuterium, tritium and carbon-14 (preclinical and phase 0 clinical evaluation), and fluorine-18 (phase I-III clinical trials); 2) to educate a new generation of young talented PhD students specialized in the radiolabeling of biologics through a combination of interdisciplinary lab research, transdisciplinary and intersectorial secondments, technical taught courses, scientific lectures and complementary skills workshops; 3) to ensure the appropriate dissemination, exploitation and communication of all ISOBIOTICS outputs in order to maximize the project's impact and radiance; 4) to secure the students employment and the sustainability of training structures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring and Driving Cooperative International Strategies in Sustainable Chiral Pool Natural Product Synthesis
  • 批准号:
    BB/W018705/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $4.42万
  • 财政年份:
    2022
  • 负责人:
    Benjamin Davis
  • 依托单位:
Radical Radiochemistry for Site- and Copy-Controlled 18F-Labeling of Proteins
  • 批准号:
    BB/V010999/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $107.73万
  • 财政年份:
    2021
  • 负责人:
    Benjamin Davis
  • 依托单位:
Rosalind Franklin Institute - Next Generation Chemistry
  • 批准号:
    EP/V011359/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $474.38万
  • 财政年份:
    2020
  • 负责人:
    Benjamin Davis
  • 依托单位:
Understanding a Mutant that Disregulates Trehalose 6-Phosphate Action in Plants
  • 批准号:
    BB/T016329/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $101.75万
  • 财政年份:
    2020
  • 负责人:
    Benjamin Davis
  • 依托单位:
海外基金